Get the Stockscreener App
0.41
18.00%
-0.09
After Hours:
.39
-0.02
-4.88%
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Large Drop in Short Interest - Defense World
bioAffinity stock hits 52-week low at $0.55 amid market challenges - Investing.com Canada
BioAffinity Technologies Raises $1.4 Million After Warrant Exercise -February 26, 2025 at 12:59 pm EST - Marketscreener.com
How Will bioAffinity's $1.4M Capital Raise Impact Existing Shareholders? - StockTitan
bioAffinity's $1.4M Cash Injection Comes With 61% Warrant DiscountWhat's the Real Cost? - StockTitan
How bioAffinity's $1.4M Warrant Deal Affects Shareholder Value: Dilution vs. Cash Injection - StockTitan
bioAffinity's $1.4M Cash Infusion Comes at a Cost: Warrant Price Slashed by 61% - StockTitan
Early lung cancer diagnosis saves 52-year-old Indian man’s life - Mugglehead
Zacks Initiates Coverage of bioAffinity With Neutral Recommendation - MSN
bioAffinity Technologies faces Nasdaq delisting over price - MSN
bioAffinity Technologies faces Nasdaq delisting over price By Investing.com - Investing.com Nigeria
British scientists develop lung cancer blood test that gives results in 40 minutes - Mugglehead
The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity - Nasdaq
Top Research Reports for Amazon.com, Bank of America & Caterpillar - Nasdaq
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 16.7% – Here’s Why - Defense World
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
bioAffinity Technologies (BIAF) Stock Price, News & Analysis - MarketBeat
BIOAFFINITY TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test - Mugglehead
bioAffinity secures Australian patent for lung cancer test - MSN
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic - BioSpace
bioAffinity Technologies stock hits 52-week low at $0.65 - MSN
Biotech company CEO receives pay bump - San Antonio Business Journal
bioAffinity Technologies Increases CEO Maria Zannes’ Annual Base Salary to $300,000 - Defense World
bioAffinity Technologies Adjusts CEO Compensation Package - TipRanks
bioAffinity Technologies CEO receives salary increase - Investing.com
bioAffinity Technologies (NASDAQ:BIAFW) Trading Up 4.7% – Time to Buy? - Defense World
bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung - BioSpace
bioAffinity's Breakthrough Lung Cancer Test Shows 92% Accuracy, Could Save Medicare $379M - StockTitan
Enlivex CEO to Showcase Breakthrough Allocetra Cell Therapy on Bloomberg TV Special Feature - StockTitan
**bioAffinity Technologies Reports Results of 2024 Special Meeting** - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Shares Down 2% – Here’s Why - Defense World
bioAffinity Technologies Boosts Sales with CyPath Lung - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 25.7% – Time to Sell? - Defense World
San Antonio biotech company looks to expand in 2025 - The Business Journals
bioAffinity Tech to Showcase Breakthrough Lung Cancer Detection Test in Exclusive Investor Webinar - StockTitan
Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19 - Business Wire
Flow Cytometry in Oncology Market is Likely to Increase At - openPR
bioAffinity Technologies stock hits 52-week low at $0.91 By Investing.com - Investing.com UK
William Bauta to Spearhead Product Development at bioAffinity Technologies - MPO-mag
bioAffinity Technologies Set for Continued Expansion in 2025 - BioSpace
BioAffinity Technologies Set for Continued Expansion in 2025 - Marketscreener.com
bioAffinity Technologies Adds Japanese Patent to its IP Portfolio - MPO-mag
8.02%
2.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):